Yuto Matsushita

Hamamatsu, 4313192, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 131 publications

Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50.

Deep learning-based automated identification of papillary bladder cancer from endoscopic still images using SE-ResNeXt-50.

Journal: World journal of urology

Published: May 17, 2026

Multimodal Treatment for Female Primary Urethral Carcinoma: A Three-Case Series Utilizing Robot-Assisted Radical Cystectomy and Extended Resection.

Multimodal Treatment for Female Primary Urethral Carcinoma: A Three-Case Series Utilizing Robot-Assisted Radical Cystectomy and Extended Resection.

Journal: IJU case reports

Published: April 27, 2026

Clinical benefits, tolerability, and risk factors of adjuvant nivolumab for muscle-invasive bladder cancer.

Clinical benefits, tolerability, and risk factors of adjuvant nivolumab for muscle-invasive bladder cancer.

Journal: Translational andrology and urology

Published: April 11, 2026

Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.

Development of a Prognostic Model for Patients Aged ≤65 Years With Metastatic Renal Cell Carcinoma.

Journal: Anticancer research

Published: April 02, 2026

Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter Study.

Real-World Outcomes and Prognostic Factors of Immune Checkpoint Inhibitor Rechallenge for Metastatic Renal Cell Carcinoma: A Multicenter Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 31, 2026

Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.

Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma.

Journal: Anticancer research

Published: March 26, 2026

Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.

Development of a prognostic model for elderly patients with metastatic clear cell renal cell carcinoma treated with first-line immuno-oncology combination therapy.

Journal: Japanese journal of clinical oncology

Published: March 16, 2026

Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.

Comparative Efficacy of First-Line Immune Checkpoint Inhibitor-Based Combination Therapies in Patients With Sarcomatoid Renal Cell Carcinoma: A Japanese Multicenter Cohort Study.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: February 24, 2026

Inferior Vena Cava Thrombosis After Nephrectomy of the Native Kidneys in Patients With Autosomal Dominant Polycystic Kidney Disease.

Inferior Vena Cava Thrombosis After Nephrectomy of the Native Kidneys in Patients With Autosomal Dominant Polycystic Kidney Disease.

Journal: IJU case reports

Published: December 15, 2025

Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study.

Enfortumab vedotin demonstrates consistent efficacy in platinum- and ICI-refractory metastatic urothelial carcinoma patients irrespective of prior response: a multicenter real-world study.

Journal: Central European journal of urology

Published: December 12, 2025

Robot-Assisted Radical Cystectomy Using the Hinotori Surgical System in Patients With Previous Prostate Cancer Treatment: A Single-Institution Case Series.

Robot-Assisted Radical Cystectomy Using the Hinotori Surgical System in Patients With Previous Prostate Cancer Treatment: A Single-Institution Case Series.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 07, 2025

Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.

Oncological Outcomes and Prognostic Factors of Platinum-Based Chemotherapy Followed by Avelumab Maintenance Therapy Compared With Platinum-Based Chemotherapy Alone: A Propensity Score-Matched Analysis in a Real-World Population.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: November 27, 2025

Showing 1-12 of 131

Last Updated: 09/26/2026